Oryzon Genomics (Spain) Investor Sentiment

ORY Stock  EUR 1.56  0.02  1.27%   
About 62% of Oryzon Genomics' investor base is looking to short. The analysis of current outlook of investing in Oryzon Genomics SA suggests that many traders are alarmed regarding Oryzon Genomics' prospects. The current market sentiment, together with Oryzon Genomics' historical and current headlines, can help investors time the market. In addition, many technical investors use Oryzon Genomics SA stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Oryzon Genomics Positive Signals From First ALICE Trial Dataset - Investing.com
Google News at Macroaxis
over a week ago at news.google.com         
Oryzon Genomics First Look At Ory 1001 Phase IIia Data - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Oryzon Genomics to List New Shares on Spanish Exchanges - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Oryzon Genomics Advances Clinical Trials Amid Financial Adjustments - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Growth Investors Industry Analysts Just Upgraded Their Oryzon Genomics S.A. Revenue Forecasts By 54 ...
Google News at Macroaxis
over two months ago at news.google.com         
Oryzon Genomics Announces Positive BPD Trial Results - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional Decision to Gran...
Google News at Macroaxis
over three months ago at news.google.com         
ORYZON reports financial results and corporate update for half-year ending June 30, 2024 - Yahoo Fin...
Google News at Macroaxis
over three months ago at news.google.com         
Oryzon Genomics Bonds Converted to Shares - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Oryzon Genomics Expands Capital with New Shares - TipRanks.com - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Oryzon Genomics Announces Capital Increase and New Shares - TipRanks.com - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Oryzon Genomics Announces Capital Increase - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
ORYZON Reports Financial Results and Corporate Update for the 1st Quarter, 2017 - Yahoo News UK
Google News at Macroaxis
over six months ago at news.google.com         
ORYZON to Provide Corporate Progress Updates at Several Events in May - Investing.com India
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Oryzon Genomics that are available to investors today. That information is available publicly through Oryzon media outlets and privately through word of mouth or via Oryzon internal channels. However, regardless of the origin, that massive amount of Oryzon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oryzon Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oryzon Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oryzon Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oryzon Genomics alpha.

Oryzon Genomics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Oryzon Stock analysis

When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like